Zurich Cantonal Bank
CRL icon

Zurich Cantonal Bank’s Charles River Laboratories CRL Stock Holding History

Zurich Cantonal Bank’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,796
Closed -$2.95M – 2803
2025
Q4 		$2.95M Buy
+14,796
New +$2.68M 0.01% 801

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Zurich Cantonal Bank's CRL Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Charles River Laboratories (CRL) in Q1 2026: 17,095 shares worth $2.95M. The stake represents 0.01% of the portfolio and ranks #845 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in CRL as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in CRL in Q1 2015 and has held it in 44 quarters since. The position peaked at $6.2M in Q2 2023. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Zurich Cantonal Bank held 17,095 shares of Charles River Laboratories worth $2.95M as of Q1 2026.
  • Charles River Laboratories was a new Zurich Cantonal Bank position in Q1 2026.
  • Charles River Laboratories made up 0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #845 holding.
  • Zurich Cantonal Bank first reported a position in Charles River Laboratories in Q1 2015 and has held it in 44 quarters since.
  • Zurich Cantonal Bank's Charles River Laboratories position peaked at $6.2M in Q2 2023.
  • 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.